IP Library › Granted Patent US 8,173,196
Granted Patent B2
US 8,173,196 · App. 11/531,512 · Granted May 8, 2012

Method of coating a stent with a polysaccharide layer and associated stents

Assignee: Biotronik Mess-und Therapiegeraete GmbH & Co.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,173,196
App. No.
11/531,512
Granted
May 8, 2012
Kind
B2
Abstract

The invention concerns methods of coating stents and stents produced in accordance therewith. The object of the invention is to provide methods of coating stents with a polysaccharide layer which has improved adhesion capacity on the substrate surface of the implant, and to afford correspondingly functionalized stents. That is achieved inter alia by covalent bonding of a non-crosslinked hyaluronic acid to a substrate surface of the stent with the formation of hyaluronic acid layer and crosslinking of the hyaluronic acid layer.

Claims (44)

1. A method of coating a surface of a stent with a polysaccharide layer the method comprising the steps of:

providing the stent with a surface prepared for covalent bonding of a polysaccharide thereto;

bonding a non-crosslinked hyaluronic acid covalently to the prepared surface, thereby providing a first non-crosslinked hyaluronic acid layer;

covalent bonding of a crosslinked layer of hyaluronic acid to the first non-crosslinked hyaluronic acid layer; wherein an active substance is present in at least one of the polysaccharide layers.

2. A method of coating a surface of a stent with a polysaccharide layer, the method comprising the steps of:

providing a stent with a surface prepared for the bonding of polysaccharide thereto by bonding a bonding agent layer to the substrate surface;

covalent bonding of a non-crosslinked first layer of chitosan to the bonding agent layer forming a chitosan layer;

bonding a layer of crosslinked hyaluronic acid covalently to the non-crosslinked chitosan; wherein an active substance is provided in at least one of the polysaccharide layers.

3. A method according to claim 2 , wherein:

the active substance is provided by means of a spraying or immersion process prior to the step of bonding a layer of crosslinked hyaluronic acid covalently to the chitosan.

4. A method according to claim 2 , wherein:

the active substance is embedded after crosslinking and fixing of the polysaccharide layers in the swollen condition.

5. The method according claim 4 , wherein:

the active substance is Cyclosporin.

6. The method according claim 2 , wherein:

the active substance is Cyclosporin.

7. The method according claim 2 , wherein the active substance is embedded by means of a spraying or immersion process during coating with the polysaccharide.

8. The method according claim 7 , wherein:

the active substance is Cyclosporin.

9. A method according to claim 2 , wherein:

the secondary layer is thicker than the first polysaccharide layer.

10. A method according to claim 9 , wherein:

the active substance is provided by means of a spraying or immersion process prior to the step of bonding a layer of crosslinked hyaluronic acid covalently to the chitosan.

11. The method according claim 10 , wherein:

the active substance is Cyclosporin.

12. The method according claim 9 , wherein:

the active substance is Cyclosporin.

13. The method according claim 9 , wherein the active substance is embedded by means of a spraying or immersion process during coating with the polysaccharide.

14. The method according claim 13 , wherein:

the active substance is Cyclosporin.

15. A method of coating a surface of a stent with a polysaccharide layer, the method comprising the steps of:

providing a stent with a surface prepared for the bonding of polysaccharide thereto by bonding a bonding agent layer to the substrate surface;

covalent bonding of a non-crosslinked first layer of chitosan to the bonding agent layer forming a chitosan layer;

bonding a layer of non-crosslinked hyaluronic acid covalently to the chitosan;

embedding an active substance in the polysaccharide layers.

16. A method according to claim 15 wherein:

the secondary layer is thicker than the first polysaccharide layer.

17. A method according to claim 15 , wherein:

the active substance is embedded after crosslinking and fixing of the polysaccharide layers in the swollen condition.

18. A method according to claim 15 , wherein:

the active substance is provided by means of a spraying or immersion process prior to the step of bonding a layer of crosslinked hyaluronic acid covalently to the chitosan.

19. The method according claim 15 , wherein the active substance is embedded by means of a spraying or immersion process during coating with the polysaccharide.

20. The method according claim 15 , wherein:

the active substance is Cyclosporin.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2012
From: BAYER, GERD; NAGEL, MARKUS; BORCK, ALEXANDER
To: BIOTRONIK MESS- UND THERAPIEGERAETE GMBH & CO. INGENIEURBUERO BERLIN
Reel/Frame 027997/0017 →
Priority Claims (1)
DE 102 23 310 · May 24, 2002 · national
Continuity (2)
Division 10444827 · May 23, 2003
Related Publication 20070026038A1 · Feb 1, 2007